Medigene AG (FRA:MDG1)
€ 1.2 -0.025 (-2.04%) Market Cap: 35.81 Mil Enterprise Value: 22.09 Mil PE Ratio: 0 PB Ratio: 1.49 GF Score: 59/100

Q4 2023 Medigene AG Earnings Call Transcript

Mar 28, 2024 / 02:00PM GMT
Release Date Price: €2.14 (+6.60%)
Operator

Ladies and gentlemen, welcome to the Medigene AG full-year 2023 earnings call and live webcast. I am Sandra, the chorus call operator. (Operator Instructions)

At this time, it's my pleasure to hand over to Pamela Keck. Please go ahead.

Pamela Keck
Medigene AG - VP, IR and Corporate Communications

Welcome, everyone, and thank you for joining us. With me today is Dr. Selwyn Ho, CEO of Medigene. Today, we announced financial results for the year ended December 31, 2023. You can access the press release on the Investor Relations page of our website at medigene.com.

Before we get started, let's quickly run through the forward-looking statements. Please note that as a part of our discussion today, management will be making forward-looking statements. Also, we believe our expectations are based on reasonable assumptions.

By their very nature, forward-looking statements involve risks and uncertainties that may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot